Clarametyx Biosciences
About:
Clarametyx Biosciences is a late preclinical stage biotechnology company.
Website: https://clarametyx.com/
Top Investors: Rev1 Ventures, Nationwide Children's Hospital, 1776 Ventures, Cystic Fibrosis Foundation, JobsOhio
Description:
Clarametyx Biosciences is a late preclinical stage biotechnology company developing targeted, immune-enabling biologic therapies to counter persistent infections associated with biofilms.
Total Funding Amount:
$59.2M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Columbus, Ohio, United States
Founded Date:
2020-01-01
Contact Email:
info(AT)clarametyx.com
Founders:
Michael Triplett, Peter Kleinhenz
Number of Employees:
11-50
Last Funding Date:
2024-01-05
IPO Status:
Private
Industries:
© 2025 bioDAO.ai